Australia - engleză - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - clindamycin phosphate, quantity: 357 mg (equivalent: clindamycin, qty 300 mg) - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections; disodium edetate - clindamycin viatris is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria.,clindamycin viatris is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci and staphylococci.,its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgement of the physician, a penicillin is inappropriate.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - tobramycin, quantity: 60 mg/ml - inhalation, conventional - excipient ingredients: water for injections; sodium hydroxide; sulfuric acid; sodium chloride - tobi is indicated for the management of cystic fibrosis patients with p.aeruginosa infections. safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with fev,<25% or >75% predicted, or patients colonised with burkolderia cepacia (see clinical trials).

Australia - engleză - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - tobramycin, quantity: 300 mg - inhalation, conventional - excipient ingredients: sodium hydroxide; sulfuric acid; nitrogen; water for injections; sodium chloride - tobramycin solution is indicated for the management of cystic fibrosis patients with p. aeruginosa infections.,safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with fev1 ? 25 % or ? 80 % predicted at screening, or patients colonized with burkholderia cepacia (see clinical trials).

Australia - engleză - Department of Health (Therapeutic Goods Administration)

maple healthcare pty ltd - tobramycin, quantity: 60 mg/ml - inhalation, conventional - excipient ingredients: sodium hydroxide; sodium chloride; sulfuric acid; water for injections - tobramycin wockhardt solution is indicated for the management of cystic fibrosis patients with p. aeruginosa infections.,safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with fev1 less than or equal to 25 percent or more than or equal to 80 percent predicted at screening, or patients colonized with burkholderia cepacia (see clinical trials).

Australia - engleză - Department of Health (Therapeutic Goods Administration)

luminarie pty ltd - tobramycin, quantity: 60 mg/ml - inhalation, conventional - excipient ingredients: sodium hydroxide; sulfuric acid; water for injections; sodium chloride - tobramycin wkt solution is indicated for the management of cystic fibrosis patients with p. aeruginosa infections.,safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with fev1 less than or equal to 25 percent or more than or equal to 80 percent predicted at screening, or patients colonized with burkholderia cepacia (see clinical trials).

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - heparin sodium - solution injection or concentrate for solution infusion - 1000 international unit(s)/millilitre - heparin group; heparin

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - heparin sodium - solution injection or concentrate for solution infusion - 1000 international unit(s)/millilitre - heparin group; heparin

Australia - engleză - Department of Health (Therapeutic Goods Administration)

mega lifesciences (australia) pty ltd - magnesium amino acid chelate,manganese amino acid chelate,pyridoxine hydrochloride,zinc amino acid chelate -

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

viatris limited - tobramycin 28mg - powder filled inhalation capsule - 28 mg - active: tobramycin 28mg excipient: butyl alcohol calcium chloride dihydrate carnauba wax carrageenan distearoyl-dl-phosphatidylcholine hypromellose indigo carmine aluminium lake isopropyl alcohol potassium chloride propylene glycol shellac sulfuric acid titanium dioxide water for injection - management of cystic fibrosis patients with pseudomonas aeruginosa infections.

Israel - engleză - Ministry of Health

dexcel ltd, israel - tobramycin - solution for inhalation - tobramycin 300 mg / 5 ml - tobramycin - tobramycin - tobi is indicated for the management of pulmonary pseudomonas aeruginosa infection in cystic fibrosis (cf) patients age 6 years or older.